Optimize Financial Inc Day One Biopharmaceuticals, Inc. Transaction History
Optimize Financial Inc
- $128 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding DAWN
# of Institutions
196Shares Held
76.7MCall Options Held
138KPut Options Held
208K-
Atlas Venture Life Science Advisors, LLC6.43MShares$43.7 Million14.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.94MShares$40.4 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$39.1 Million0.95% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$30.8 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL4.06MShares$27.6 Million0.14% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $500M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...